Topics
November/December 2018 | Subfocus: The Best Of Retina
A Review of All Things Retina
Looking back at some of the field's exciting developments over the past 12 months.
Michele Corry
May 29, 2026
Oculis Does Not Meet Primary Endpoint in Phase 3 DIAMOND Program of OCS-01 in DME
Study Finds Atopic Dermatitis May Raise Risk of Retinal Detachment
Samsung Bioepis Launches Opuviz Aflibercept Biosimilar Across Europe
May 28, 2026
Therini Bio Doses First Patients in Phase 1b Trial of THN391 for DME
April 2026 Insert
Editorially independent supported by Abbvie and Regenxbio
April 2026 Supplement
Editorially independent content supported with advertising by EyePoint
Free Print Subscription
Email Newsletter
Conference Calendar
